This is a type of Leishmaniasis that affects the skin. It causes widespread skin sores or lesions all over the body. It doesn't usually affect the internal organs, like the liver or spleen.
Every report comes from a Lived member, sent anonymously.
Have you tried Antimony Sodium Gluconate for Diffuse Cutaneous Leishmaniasis?
Diffuse cutaneous leishmaniasis (DCL) is a rare, long-lasting form of leishmaniasis, a parasitic infection spread by sand flies. In the more familiar skin form, one or a few sores appear and often heal on their own over months. In DCL, the immune system fails to mount the targeted response that normally keeps the parasite in check, so the infection keeps spreading through the skin instead. It often begins as a single painless lump. Over months to years, many firm nodules, raised patches and thickened plaques appear across the face, arms, legs and trunk, sometimes merging into larger areas. Unlike typical skin leishmaniasis, these lesions usually do not break open into ulcers. DCL stays in the skin: it does not affect internal organs or the lining of the nose and mouth. Its main harms are its persistence, its tendency to come back after treatment, and the visible, sometimes disfiguring changes it causes. DCL is often confused with disseminated cutaneous leishmaniasis, a different form that also produces many skin lesions but involves a strong immune response, frequently ulcerates, can affect the nose and mouth, and generally responds better to standard drugs.
Leishmania parasites pass to people through the bite of infected female sand flies, tiny insects that are most active from dusk to dawn. DCL is caused by particular parasite species: mainly Leishmania aethiopica in the highlands of Ethiopia and in Kenya, and Leishmania amazonensis and Leishmania mexicana in parts of Central and South America and Mexico. Most people bitten by an infected sand fly never develop DCL. Even in places where skin leishmaniasis is common, DCL accounts for only a tiny fraction of cases. What tips an infection toward this diffuse form is mainly the person's immune response. DCL is associated with weakened cell-mediated immunity, the part of the immune system that uses T cells to direct infection-fighting cells. HIV infection is a recognized risk, and DCL has occasionally been the first sign that someone had HIV. However, many people with DCL have no known immune problem, and researchers believe some parasite strains and a large initial dose of parasites may also play a role. There is no vaccine and no preventive medicine. In areas where leishmaniasis occurs, the practical protection is avoiding sand fly bites: staying indoors or under fine-mesh netting from dusk to dawn, wearing long sleeves and pants, and using insect repellent.
Diagnosis starts with the pattern of skin changes and where the person has lived or traveled. Because DCL is rare and can look like other conditions, especially the lepromatous form of leprosy, it needs laboratory confirmation. A clinician takes a skin scraping or a small biopsy from a lesion. In DCL, the sample is typically packed with parasites, which can be seen under a microscope inside immune cells. Tests that detect the parasite's genetic material (polymerase chain reaction, or PCR) are the most sensitive option, and specialist reference laboratories can identify the exact species. That matters because the species helps separate DCL from disseminated cutaneous leishmaniasis and guides the choice of drug. In some countries, a leishmanin skin test is used to measure the immune reaction to the parasite. It is usually negative in DCL, reflecting the missing immune response. This test is not available in the United States or Canada. Testing for HIV and other causes of a weakened immune system is often part of the workup.
DCL is one of the hardest forms of leishmaniasis to treat, and no single drug reliably cures it. Treatment uses systemic medicines, taken by mouth or given by injection or infusion, rather than creams or local treatments applied to individual lesions. The choice depends on the parasite species, the region where the infection was acquired, other health conditions, pregnancy and how well each drug is tolerated. Commonly used options include antimony-based medicines (pentavalent antimonials, given by injection), amphotericin B (an antifungal medicine given by infusion that also kills Leishmania), paromomycin (an injected antibiotic, sometimes combined with an antimonial) and pentamidine. Miltefosine (Impavido) is an oral antiparasitic medicine. Its US approval covers other Leishmania species, so its use in DCL is off-label. Because miltefosine can harm a developing baby, it is not used during pregnancy, and people who could become pregnant need effective contraception during treatment and for five months afterward. Lesions often shrink while a person is on treatment, then return once it stops. For that reason, doctors may use long courses, combinations of drugs, or treatment that continues well after the skin looks better. Individual case reports describe lasting remission after months of miltefosine or after an antimonial followed by long-term allopurinol (a gout medicine with some activity against the parasite), but these are single cases, not proof that they will work for everyone. Some reports suggest treatment started early in the illness has a better chance of success. For people with HIV, effective HIV treatment is an important part of care because restoring the immune system helps control the infection.
DCL is usually a long-term condition. Without effective treatment it tends to progress slowly over years, and it can last for decades. Even with treatment, many people go through cycles of improvement and relapse, and some need several different regimens. Lasting remission is possible, but it cannot be predicted for an individual. Because the condition rarely causes pain and stays in the skin, the larger burdens are often the length of treatment, the side effects of the drugs, frequent clinic visits and the visible changes to the face and body. Many people find these changes affect work, relationships and how they feel in public. Care is often coordinated by infectious disease or tropical medicine specialists and dermatologists, with regular checks of the skin to see whether lesions are shrinking or returning, and blood tests to watch for drug side effects. Follow-up usually continues for a long time after the skin clears, since relapse can occur months or years later.
Arrange a medical evaluation if you develop painless lumps, nodules or thickened patches of skin that persist or keep spreading and you have lived in or traveled to an area where leishmaniasis occurs, even if the trip was long ago. Mention the travel history, since leishmaniasis is uncommon in the United States and may not be considered otherwise. If you are being treated or have finished treatment, contact your care team if new nodules appear or old ones start to grow again, if lesions become red, hot, swollen or draining (signs of a bacterial infection), or if you have side effects from the medicines. Tell the team promptly if you become pregnant or could be pregnant while taking a medicine such as miltefosine.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Diffuse Cutaneous Leishmaniasis is like, what's helped you, or ask the community a question.